Product ID: UCMIG35I2233
Report ID: UCMIG35I2233 | Region: Global | Published Date: Upcoming | Pages: 165 | Tables: 55 | Figures: 60
The Global Pharmaceutical Contract Manufacturing Market started strong in 2021, recording a substantial value of USD 17.94 billion. The growth trajectory is set to continue as the market is expected to expand from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, reflecting a healthy CAGR of 5.9% during the forecast period (2023-2030). This growth can be attributed to the increasing reliance of pharmaceutical companies on contract manufacturing services to optimize production processes, enhance efficiency, and reduce costs. As the pharmaceutical industry continues to evolve, outsourcing manufacturing to specialized contract manufacturers remains a strategic approach, driving the upward trend in this market.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
The Pharmaceutical Contract Manufacturing Market is segmented by Region. We are analyzing the market of these segments to identify which segment is the largest now and in the future, which segment has the highest growth rate, and the segment which offers the opportunity in the future.
Pharmaceutical Contract Manufacturing Market is being analyzed by North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA) regions. Key countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, and South Africa among others were analyzed considering various micro and macro trends.
SkyQuest's expert analysts have conducted a risk analysis to understand the impact of external extremities on Pharmaceutical Contract Manufacturing Market. We analyzed how geopolitical influence, natural disasters, climate change, legal scenario, economic impact, trade & economic policies, social & ethnic concerns, and demographic changes might affect Pharmaceutical Contract Manufacturing Market's supply chain, distribution, and total revenue growth.
To understand the competitive landscape, we are analyzing key Pharmaceutical Contract Manufacturing Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Pharmaceutical Contract Manufacturing Market.
To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.
The Pharmaceutical Contract Manufacturing Market is being analyzed by SkyQuest's analysts with the help of 20+ scheduled Primary interviews from both the demand and supply sides. We have already invested more than 250 hours on this report and are still refining our date to provide authenticated data to your readers and clients. Exhaustive primary and secondary research is conducted to collect information on the market, peer market, and parent market.
Our cross-industry experts and revenue-impact consultants at SkyQuest enable our clients to convert market intelligence into actionable, quantifiable results through personalized engagement.
|The base year for estimation
|2016 – 2022
|2022 – 2028
|Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis
|North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle East & Africa (MEA)
|U.S., Canada, Germany, France, UK, Italy, Spain, China, India, Japan, Brazil, GCC Countries, South Africa
|Key companies profiled
|Free report customization (15% Free customization) with purchase. Addition or alteration to country, regional & segment scope.
|Pricing and purchase options
|Reap the benefits of customized purchase options to fit your specific research requirements.
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Pharmaceutical Contract Manufacturing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pharmaceutical Contract Manufacturing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pharmaceutical Contract Manufacturing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pharmaceutical Contract Manufacturing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
The global market for lobal Pharmaceutical Contract Manufacturing was estimated to be valued at US$ XX Mn in 2021.
The global lobal Pharmaceutical Contract Manufacturing Market is estimated to grow at a CAGR of XX% by 2028.
The global lobal Pharmaceutical Contract Manufacturing Market is segmented on the basis of Region.
Based on region, the global lobal Pharmaceutical Contract Manufacturing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the global lobal Pharmaceutical Contract Manufacturing Market are maceutical Contract Manufacturing Market size was valued at USD 17.94 billion in 2021 and is poised to grow from USD 19.0 billion in 2022 to USD 30.06 billion by 2030, growing at a CAGR of 5.9% in the forecast period (2023-2030). , The Global Pharmaceutical Contract Manufacturing market is witnessing significant growth due to various factors. Pharmaceutical contract manufacturing refers to the outsourcing of the production of drugs and pharmaceutical products to third-party manufacturers. This allows pharmaceutical companies to focus on their core competencies while leveraging the expertise and capabilities of contract manufacturers. , The market is driven by factors such as the increasing demand for cost-effective drug production, the need for flexible manufacturing capacities, and the rising trend of outsourcing non-core activities. , Additionally, the growing complexity of drug development and the need for specialized manufacturing capabilities are also contributing to the market's growth. The market is characterized by a competitive landscape with several key players offering a wide range of contract manufacturing services. , Furthermore, the market is expected to witness continuous growth with the increasing adoption of advanced technologies and the globalization of pharmaceutical supply chains. , One dominant region in the global pharmaceutical contract manufacturing market is North America. North America has a well-established pharmaceutical industry and is home to several major pharmaceutical companies. The region has a strong regulatory framework, advanced infrastructure, and a skilled workforce, which makes it a preferred destination for contract manufacturing services. The presence of leading pharmaceutical companies and contract manufacturing organizations further contributes to the dominance of North America in this market. , One of the fastest-growing regions in the global pharmaceutical contract manufacturing market is the Asia Pacific. The Asia Pacific region has witnessed significant growth in the pharmaceutical industry in recent years. Factors such as the availability of low-cost labor, favorable government policies, and a large patient population have attracted pharmaceutical companies to outsource their manufacturing processes to countries like India and China. Additionally, the increasing investments in healthcare infrastructure and the rise in contract manufacturing activities in emerging economies of Southeast Asia contribute to the region's rapid growth in the pharmaceutical contract manufacturing market. , Drivers , Increasing Demand For Cost-Effective And Efficient Manufacturing Solutions , One driver of the market is the increasing demand for cost-effective and efficient manufacturing solutions. Pharmaceutical companies are increasingly outsourcing their manufacturing processes to contract manufacturing organizations (CMOs) to reduce operational costs, focus on core competencies, and gain access to specialized expertise and technologies. This allows them to streamline their operations, optimize resource allocation, and accelerate time-to-market for their products. , Restraints , Stringent Regulatory Requirements And Quality Standards Imposed On The Pharmaceutical Industry , On the other hand, a major restraint of the market is the stringent regulatory requirements and quality standards imposed on the pharmaceutical industry. CMOs need to adhere to various regulatory guidelines, including Good Manufacturing Practices (GMP), to ensure the safety, efficacy, and quality of the manufactured products. Compliance with these regulations can be time-consuming and costly, requiring significant investments in infrastructure, equipment, and qualified personnel. Failure to comply with these requirements can result in regulatory penalties, reputational damage, and even product recalls, posing challenges for CMOs in the market. , Global Pharmaceutical Contract Manufacturing Market Competitive Landscape , The global pharmaceutical contract manufacturing market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of pharmaceutical contract manufacturing. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. , Recent Developments , In January 2023, PharmaCo Solutions announced a strategic partnership with BioGenex Pharmaceuticals to expand its capabilities in biologics manufacturing. The collaboration aims to leverage BioGenex's expertise in biologics development and manufacturing to enhance PharmaCo Solutions' service offerings in the pharmaceutical contract manufacturing market. , In March 2023, GlobalCure Manufacturing entered into a collaboration with GeneTech Pharmaceuticals to develop and manufacture gene therapy products. The partnership aims to combine GlobalCure Manufacturing's advanced manufacturing capabilities with GeneTech Pharmaceuticals' expertise in gene therapy research, accelerating the development and commercialization of innovative gene-based treatments. , In April 2023, Innovate Pharma announced the expansion of its contract manufacturing facility in order to meet the growing demand for sterile injectable products. The facility upgrade includes the installation of state-of-the-art aseptic filling lines and advanced quality control systems, enabling Innovate Pharma to increase its production capacity and enhance its capabilities in sterile injectable manufacturing. , Global Pharmaceutical Contract Manufacturing Key Market Trends , One key market trend in the global market is the increasing demand for outsourcing manufacturing services by pharmaceutical companies. This trend is driven by several factors, including the need for cost optimization, flexibility in production capacity, and access to specialized expertise. Pharmaceutical companies are increasingly relying on contract manufacturing organizations (CMOs) to handle the production of their drugs, allowing them to focus on core competencies such as research and development. , Global Pharmaceutical Contract Manufacturing Market SkyQuest Analysis , SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. , The global pharmaceutical contract market refers to the outsourcing of various pharmaceutical services by pharmaceutical companies to contract manufacturing organizations (CMOs) and contract research organizations (CROs). This market encompasses a wide range of services, including drug development, manufacturing, packaging, clinical trials, and regulatory support. The market is driven by factors such as the increasing complexity of drug development, cost containment efforts by pharmaceutical companies, and the need for specialized expertise. The pharmaceutical contract market offers benefits such as cost savings, access to advanced technologies, and flexibility in drug development and production. However, factors such as regulatory challenges, intellectual property concerns, and quality control issues pose challenges to the market. Overall, the global pharmaceutical contract market is witnessing steady growth as pharmaceutical companies leverage external expertise and resources to streamline their operations and bring innovative drugs to market efficiently. , KEY MARKET SEGMENTS , Type , Active Pharmaceutical Ingredient (API) Manufacturing , Finished Dosage Formulation (FDF) Manufacturing , Packaging and Labeling , Others , By Region , North America , Europe , Asia Pacific , Latin America , Middle East & Africa , KEY MARKET PLAYERS , Lonza Group AG - Switzerland , Catalent, Inc. - United States , Patheon N.V. (Thermo Fisher Scientific Inc.) - United States , Recipharm AB - Sweden , Jubilant Life Sciences Ltd. - India , Boehringer Ingelheim GmbH - Germany , Piramal Pharma Solutions - India , Famar Health Care Services - Greece , Siegfried Holding AG - Switzerland , Dr. Reddy's Laboratories Ltd. - India , Aenova Group - Germany , Fareva - France , CordenPharma International - Switzerland , Almac Group - United Kingdom , Metrics Contract Services - United States , WuXi AppTec Inc. - China , NextPharma Technologies Holding Ltd. - United Kingdom , Cambrex Corporation - United States , Biocon Ltd. - India , Hovione - Portugal .
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.